TipRanks
Advertisement
Advertisement
Capricor Earnings Call: Daramycin Data vs. Delays
PremiumCompany AnnouncementsCapricor Earnings Call: Daramycin Data vs. Delays
1M ago
Capricor Therapeutics call volume above normal and directionally bullish
Premium
The Fly
Capricor Therapeutics call volume above normal and directionally bullish
1M ago
Capricor Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Capricor Therapeutics upgraded to Outperform from Perform at Oppenheimer
1M ago
Capricor announces extension of FDA action date for Deramiocel
PremiumThe FlyCapricor announces extension of FDA action date for Deramiocel
1M ago
Capricor says FDA extends action date for Deramiocel for amendment review
Premium
The Fly
Capricor says FDA extends action date for Deramiocel for amendment review
1M ago
Capricor Therapeutics jumps 18% to $7.42 as FDA reviews Deramiocel
Premium
The Fly
Capricor Therapeutics jumps 18% to $7.42 as FDA reviews Deramiocel
1M ago
Capricor Therapeutics expects cash to fund operations for at least 12 months
PremiumThe FlyCapricor Therapeutics expects cash to fund operations for at least 12 months
2M ago
Capricor Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
Premium
The Fly
Capricor Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
2M ago
Cantor upgrades Capricor on ‘major update’ from earnings call
Premium
The Fly
Cantor upgrades Capricor on ‘major update’ from earnings call
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―